Real-life safety assessment of orally disintegrating desmopressin tablet: Incidence of diagnosed hyponatraemia and other events across three European countries
Results from this real-life study does not indicate any added safety concerns related to use of ODT, since increased rate of hyponatraemia is already in the SmPC.
Authors
- Jonas Reinold (ORCID: https://orcid.org/0000-0001-8266-2574)
- Tarris D. Rosell
- Melcher Falkenberg
- Lene Holdrup
- Kristian Vinter Juul (ORCID: https://orcid.org/0000-0002-2233-1746)
- Gunnar Johansson
- Leif Jørgensen
- Nelly L Shapero
- Niklas Koenen
- Christian Frøsig
Institutions
- Uppsala University (SE)
- University of Cambridge (GB)
- Tennessee College of Applied Technology - Shelbyville (US)
- Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
- Ferring Pharmaceuticals (Denmark) (DK)
Publication Details
- Journal
- Global Epidemiology
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1016/j.gloepi.2025.100228
- Citations
- 1
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.52